BRCA1 and cancer: Here, we identify a novel mechanism for acquired PARP inhibitor resistance by demonstrating that phosphorylation of ribosomal protein S6, a downstream effector of the mTOR pathway, mediates PARP inhibitor resistance through attenuating the DNA damage response and restoring defective HR in BRCA1-deficient cancer cells.